应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
SITC SITE Centers Corp.
休市中 03-14 16:00:00 EDT
12.74
+0.08
+0.63%
盘后
12.74
+0.00
0.00%
16:23 EDT
最高
12.98
最低
12.66
成交量
81.95万
今开
12.66
昨收
12.66
日振幅
2.57%
总市值
6.68亿
流通市值
6.32亿
总股本
5,243万
成交额
1,050万
换手率
1.65%
流通股本
4,964万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Piper Sandler：维持SITE Centers(SITC.US)评级，由增持调整至增持评级, 目标价由20.00美元调整至19.00美元。
金融界 · 02-28
Piper Sandler：维持SITE Centers(SITC.US)评级，由增持调整至增持评级, 目标价由20.00美元调整至19.00美元。
异动解读 | SITE Centers Corp.盘中大跌6.84% 业绩重挫引发市场担忧
异动解读 · 02-27
异动解读 | SITE Centers Corp.盘中大跌6.84% 业绩重挫引发市场担忧
Site Centers Corp.盘中异动 股价大跌6.53%报13.59美元
市场透视 · 02-27
Site Centers Corp.盘中异动 股价大跌6.53%报13.59美元
异动解读 | 业绩重挫 SITE Centers盘前大跌6.46%
异动解读 · 02-27
异动解读 | 业绩重挫 SITE Centers盘前大跌6.46%
SITE Centers第四季度每股资金流为0.16美元，低于预期的0.22美元，销售额为3287万美元，低于预期的6678万美元
财报速递 · 02-27
SITE Centers第四季度每股资金流为0.16美元，低于预期的0.22美元，销售额为3287万美元，低于预期的6678万美元
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
GlobeNewswire · 02-05
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
富国银行：维持SITE Centers(SITC.US)评级，由持股观望调整至持股观望评级, 目标价由17.50美元调整至17.00美元。
金融界 · 01-30
富国银行：维持SITE Centers(SITC.US)评级，由持股观望调整至持股观望评级, 目标价由17.50美元调整至17.00美元。
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody
GlobeNewswire · 01-06
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody
Piper Sandler Keeps Their Buy Rating on SITE Centers (SITC)
TIPRANKS · 2024-12-19
Piper Sandler Keeps Their Buy Rating on SITE Centers (SITC)
IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001
GlobeNewswire · 2024-12-10
IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001
Site Centers price target lowered to $16 from $18 at Citi
TIPRANKS · 2024-12-10
Site Centers price target lowered to $16 from $18 at Citi
SITE Centers announces tax estimate for Curbline Properties distribution
TIPRANKS · 2024-11-26
SITE Centers announces tax estimate for Curbline Properties distribution
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
GlobeNewswire · 2024-11-18
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update
GlobeNewswire · 2024-11-14
MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results
GlobeNewswire · 2024-11-13
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
GlobeNewswire · 2024-11-13
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
GlobeNewswire · 2024-11-13
Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
GlobeNewswire · 2024-11-11
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
入选LBA！康宁杰瑞HER2双抗ADC皮下注射复方制剂JSKN033最新突破性临床研究结果亮相2024年SITC年会
美通社 · 2024-11-11
入选LBA！康宁杰瑞HER2双抗ADC皮下注射复方制剂JSKN033最新突破性临床研究结果亮相2024年SITC年会
康宁杰瑞逆势涨超8%，将在SITC年会公布研究成果
格隆汇 · 2024-11-11
康宁杰瑞逆势涨超8%，将在SITC年会公布研究成果
加载更多
公司概况
公司名称：
SITE Centers Corp.
所属市场：
NYSE
上市日期：
--
主营业务：
SITE Centers Corp.拥有和管理露天购物中心,为零售合作伙伴和消费者提供有吸引力的购物体验和商品组合。该公司是一家自营和自我管理的房地产投资信托基金，是一家综合性房地产公司。
发行价格：
--
{"stockData":{"symbol":"SITC","market":"US","secType":"STK","nameCN":"SITE Centers Corp.","latestPrice":12.74,"timestamp":1741982400000,"preClose":12.66,"halted":0,"volume":819541,"hourTrading":{"tag":"盘后","latestPrice":12.74,"preClose":12.74,"latestTime":"16:23 EDT","volume":25119,"amount":320016.06,"timestamp":1741983811834},"delay":0,"floatShares":49635900,"shares":52430161,"eps":13.714608,"marketStatus":"休市中","change":0.08,"latestTime":"03-14 16:00:00 EDT","open":12.66,"high":12.98,"low":12.655,"amount":10503745.57142,"amplitude":0.025671,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":13.714608,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1742198400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":12.66,"aum":0,"dividendRate":0.081633,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":13.39,"preClose":12.66,"latestTime":"04:11 EDT","volume":7,"amount":89.189996,"timestamp":1741939870486},"postHourTrading":{"tag":"盘后","latestPrice":12.74,"preClose":12.74,"latestTime":"16:23 EDT","volume":25119,"amount":320016.06,"timestamp":1741983811834},"volumeRatio":0.6744125456395338,"impliedVol":0.2129,"impliedVolPercentile":0.5301},"requestUrl":"/m/hq/s/SITC","defaultTab":"news","newsList":[{"id":"2514324770","title":"Piper Sandler：维持SITE Centers(SITC.US)评级，由增持调整至增持评级, 目标价由20.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514324770","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514324770?lang=zh_cn&edition=full","pubTime":"2025-02-28 21:44","pubTimestamp":1740750272,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持SITE Centers(SITC.US)评级，由增持调整至增持评级, 目标价由20.00美元调整至19.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28214448466735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SITE","SITC"],"gpt_icon":0},{"id":"1159191571","title":"异动解读 | SITE Centers Corp.盘中大跌6.84% 业绩重挫引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1159191571","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159191571?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:07","pubTimestamp":1740668861,"startTime":"0","endTime":"0","summary":"SITE Centers Corp.今日盘中股价大跌6.84%,引发了市场的广泛关注。\n\nSITE Centers公布了其第四季度财报,数据显示该公司当季每股收益仅为0.16美元,较分析师预期的0.22美元低了27.27%,与去年同期的1.03美元相比更是暴跌84.47%。此外,公司销售额3287万美元也大幅低于预期的6678万美元,比去年同期减少了73.31%。\n\n业绩疲弱的表现引发了市场对公司发展前景的担忧。分析人士表示,SITE Centers需要及时调整战略扭转局面,重拾提振业绩增长的步伐。投资者有必要继续关注其后续动向。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SITC"],"gpt_icon":0},{"id":"2514867933","title":"Site Centers Corp.盘中异动 股价大跌6.53%报13.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514867933?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:34","pubTimestamp":1740666842,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时34分，Site Centers Corp.股票出现波动，股价急速下挫6.53%。截至发稿，该股报13.59美元/股，成交量2.5977万股，换手率0.05%，振幅4.57%。Site Centers Corp.股票所在的房地产信托行业中，整体涨幅为0.13%。Site Centers Corp.公司简介：SITE Centers Corp，作为一家完全整合的房地产公司，是一家总部位于美国的自主管理和自我管理的房地产投资信托基金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223402abdf6f49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4080","SITC","BK4231"],"gpt_icon":0},{"id":"1103724690","title":"异动解读 | 业绩重挫 SITE Centers盘前大跌6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103724690","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103724690?lang=zh_cn&edition=full","pubTime":"2025-02-27 21:12","pubTimestamp":1740661977,"startTime":"0","endTime":"0","summary":"SITE Centers盘前股价大跌6.46%,引发了市场关注。\n\n根据最新财报显示,SITE Centers第四季度每股收益仅为0.16美元,远远低于分析师预期的0.22美元,同比下滑高达84.47%。此外,公司该季度销售额也仅为3287万美元,较预期的6678万美元低50.79%,同比更是下滑73.31%。\n\n业绩疲弱表现引发市场对公司发展前景的担忧,进而导致了盘前股价的大幅下跌。对于投资者而言,需要持续关注公司是否能够及时扭转局面,提振业绩增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 业绩重挫 SITE Centers盘前大跌6.46%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SITC"],"gpt_icon":0},{"id":"1133590344","title":"SITE Centers第四季度每股资金流为0.16美元，低于预期的0.22美元，销售额为3287万美元，低于预期的6678万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133590344","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133590344?lang=zh_cn&edition=full","pubTime":"2025-02-27 19:36","pubTimestamp":1740656199,"startTime":"0","endTime":"0","summary":"SITE Centers报告季度每股收益为0.16美元，较分析师的共识预期0.22美元低27.27%。与去年同期的1.2316亿美元销售额相比下降了73.31%。以上内容来自Benzinga Earnings专栏，原文如下：SITE Centers reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.22 by 27.27 percent. This is a 84.47 percent decrease over earnings of $1.03 per share from the same period last year. The company reported quarterly sales of $32.87 million which missed the analyst consensus estimate of $66.78 million by 50.79 percent. This is a 73.31 perce","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITE","SITC"],"gpt_icon":0},{"id":"2509319285","title":"Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels","url":"https://stock-news.laohu8.com/highlight/detail?id=2509319285","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509319285?lang=zh_cn&edition=full","pubTime":"2025-02-05 21:00","pubTimestamp":1738760400,"startTime":"0","endTime":"0","summary":"Rapid menu expansion with new high-plex human and mouse neurobiology panels joining the recently launched Human IO60 and Mouse FFPE IO Panels The new offerings solidify leadership in spatial biology a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Akoya Biosciences推出战略产品路线图，由新的IO60和即将推出的神经生物学面板提供支持","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/05/3021104/0/en/Akoya-Biosciences-Unveils-Strategic-Product-Roadmap-Powered-by-the-New-IO60-and-Upcoming-Neurobiology-Panels.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK4080","SITC","AKYA"],"gpt_icon":0},{"id":"2507658574","title":"富国银行：维持SITE Centers(SITC.US)评级，由持股观望调整至持股观望评级, 目标价由17.50美元调整至17.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507658574","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507658574?lang=zh_cn&edition=full","pubTime":"2025-01-30 00:03","pubTimestamp":1738166630,"startTime":"0","endTime":"0","summary":"富国银行：维持SITE Centers(SITC.US)评级，由持股观望调整至持股观望评级, 目标价由17.50美元调整至17.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30000347898849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SITE","SITC"],"gpt_icon":0},{"id":"2501123442","title":"NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2501123442","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501123442?lang=zh_cn&edition=full","pubTime":"2025-01-06 21:30","pubTimestamp":1736170200,"startTime":"0","endTime":"0","summary":" PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications NAYA aiming to initiate clinical trials in early 2026 SARASOTA, Fla. and M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"NAYA Biosciences宣布开发出新型AI优化PD-1 x VEGF双功能抗体NY-500","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/06/3004621/0/en/NAYA-Biosciences-Announces-Development-of-NY-500-a-Novel-AI-Optimized-PD-1-x-VEGF-Bifunctional-Antibody.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","BK4006","PD","LU0053666078.USD","BK4082","L","SITC","BK4080","BK4231","BK4107","BK4585","NAYA","HCC","LU1169590202.USD","BK4588","BK4023"],"gpt_icon":0},{"id":"2492515746","title":"Piper Sandler Keeps Their Buy Rating on SITE Centers (SITC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2492515746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492515746?lang=zh_cn&edition=full","pubTime":"2024-12-19 05:45","pubTimestamp":1734558312,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Alexander Goldfarb maintained a Buy rating on SITE Centers (SITC – Research Report) today and set a price target of $20.00. T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-keeps-their-buy-rating-on-site-centers-sitc-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"Piper Sandler维持现场中心(SITC)的买入评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-keeps-their-buy-rating-on-site-centers-sitc-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SITC","SITE"],"gpt_icon":0},{"id":"2490018295","title":"IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2490018295","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490018295?lang=zh_cn&edition=full","pubTime":"2024-12-10 21:05","pubTimestamp":1733835900,"startTime":"0","endTime":"0","summary":"Based on more than six months of additional monitoring, data show continued improvement in overall survival (OS) in intent-to-treat (ITT) population of women newly diagnosed with advanced ovarian canc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"IMUNON宣布IMNN-001随机2期OVATION 2研究的总生存期数据持续强劲改善","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/10/2994523/0/en/IMUNON-Announces-Continued-Strong-Improvement-in-Overall-Survival-Data-from-Randomized-Phase-2-OVATION-2-Study-of-IMNN-001.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4203","BK4161","BK4231","OS","BK4139","BK4080","ITT","IMNN","LU0053671581.USD","SITC","BK4097","LU0054578231.USD","BK4225","HR"],"gpt_icon":0},{"id":"2490079847","title":"Site Centers price target lowered to $16 from $18 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2490079847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490079847?lang=zh_cn&edition=full","pubTime":"2024-12-10 04:15","pubTimestamp":1733775307,"startTime":"0","endTime":"0","summary":"Citi lowered the firm’s price target on Site Centers (SITC) to $16 from $18 and keeps a Neutral rating on the shares. The firm updated its model fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/site-centers-price-target-lowered-to-16-from-18-at-citi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"花旗将Site Centers目标价从18美元下调至16美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/site-centers-price-target-lowered-to-16-from-18-at-citi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","SITC","BK4231"],"gpt_icon":0},{"id":"2486706848","title":"SITE Centers announces tax estimate for Curbline Properties distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2486706848","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486706848?lang=zh_cn&edition=full","pubTime":"2024-11-26 05:16","pubTimestamp":1732569366,"startTime":"0","endTime":"0","summary":"SITE Centers Corp. (SITC) provided additional information related to the spin-off and distribution of Curbline Properties Corp. (CURB). On October ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/site-centers-announces-tax-estimate-for-curbline-properties-distribution?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"SITE Centers宣布路边房产分配的税收估算","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/site-centers-announces-tax-estimate-for-curbline-properties-distribution?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","LU0757428866.USD","SITE","LU1815336091.USD","LU2065731478.USD","BK4231","SITC","BK4080","BK4548","CURB"],"gpt_icon":0},{"id":"2484622689","title":"Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2484622689","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484622689?lang=zh_cn&edition=full","pubTime":"2024-11-18 21:00","pubTimestamp":1731934800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor vi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Calidi Biotherapeutics展示支持RTNova全身技术靶向转移性肺癌的数据","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/18/2982741/0/en/Calidi-Biotherapeutics-Presents-Data-Supporting-RTNova-Systemic-Technology-to-Target-Metastatic-Lung-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITC","BK4080","BK4231"],"gpt_icon":0},{"id":"2483876246","title":"MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483876246","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483876246?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:00","pubTimestamp":1731585600,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc.(NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogene","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"MiNK Therapeutics报告2024年第三季度业绩和业务更新","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/14/2981009/0/en/MiNK-Therapeutics-Reports-Third-Quarter-2024-Results-and-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","INKT","BK4139","BK4231","SITC","LENZ"],"gpt_icon":1},{"id":"2483069317","title":"Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483069317","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483069317?lang=zh_cn&edition=full","pubTime":"2024-11-13 06:29","pubTimestamp":1731450540,"startTime":"0","endTime":"0","summary":"Announced FDA Clearance of the Northwestern University IND Application for NeuroNova (CLD-101) Clinical Trial in High-Grade Glioma.Presented data supporting RTNova (CLD-400), the company’s systemic an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Calidi Biotherapeutics报告2024年第三季度运营和财务业绩","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/12/2979819/0/en/Calidi-Biotherapeutics-Reports-Third-Quarter-2024-Operating-and-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITC","BK4231","BK4080"],"gpt_icon":0},{"id":"2483050810","title":"Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2483050810","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483050810?lang=zh_cn&edition=full","pubTime":"2024-11-13 05:05","pubTimestamp":1731445500,"startTime":"0","endTime":"0","summary":"Portfolio Prioritization and Corporate Restructuring Extends Cash Runway into 2Q 2026SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TS","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Turnstone Biologics Corp.报告2024年第三季度财务业绩并提供近期业务亮点","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/12/2979706/0/en/Turnstone-Biologics-Corp-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BK4080","TIL","SITC","TSBX","BK4231"],"gpt_icon":0},{"id":"2483050346","title":"Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483050346","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483050346?lang=zh_cn&edition=full","pubTime":"2024-11-13 05:05","pubTimestamp":1731445500,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empowe","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Singular Genomics报告最新更新和2024年第三季度财务业绩","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/12/2979683/0/en/Singular-Genomics-Reports-Recent-Updates-and-Third-Quarter-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","NGS","BK4179","SITC","BK4080"],"gpt_icon":0},{"id":"2482788371","title":"Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2482788371","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482788371?lang=zh_cn&edition=full","pubTime":"2024-11-11 20:00","pubTimestamp":1731326400,"startTime":"0","endTime":"0","summary":"- LV UNO in combination with anti-rPD-L1 resulted in prolonged survival and doubled the tumor growth inhibition rate in MAT B III tumor bearing rats compared to anti-rPD-L1 alone - LV UNO compares fav","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Beyond Cancer在2024年癌症免疫治疗学会(SITC)年会上展示了有关低容量超高浓度一氧化氮(LV UNO)疗法的有希望的临床前数据","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/11/2978200/0/en/Beyond-Cancer-Presents-Promising-Preclinical-Data-on-Low-Volume-Ultra-High-Concentration-Nitric-Oxide-LV-UNO-Therapy-at-the-2024-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Mee.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK4178","BK4080","BK4585","IE00B12V2V27.USD","01308","SG9999011746.SGD","BK1541","SITC","BK4588","IE00BYQNZ168.SGD","BK1103","IE00BYTNYN87.SGD"],"gpt_icon":0},{"id":"2482205012","title":"入选LBA！康宁杰瑞HER2双抗ADC皮下注射复方制剂JSKN033最新突破性临床研究结果亮相2024年SITC年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2482205012","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482205012?lang=zh_cn&edition=full","pubTime":"2024-11-11 13:04","pubTimestamp":1731301440,"startTime":"0","endTime":"0","summary":"苏州2024年11月11日 /美通社/ -- 康宁杰瑞生物制药宣布，HER2双特异性抗体偶联药物与PD-L1抑制剂的高浓度皮下注射复方制剂JSKN033的首次人体临床研究结果入选2024年第39届癌症免疫治疗学会年会最新突破性摘要，于会议期间以壁报形式首次公布。本研究进一步证明了ADC联合免疫治疗的潜力，并支持对JSKN033的持续探索。关于JSKN033 JSKN033是康宁杰瑞自主研发的全球首个抗体偶联药物和免疫检查点抑制剂的高浓度皮下注射复方制剂, 由JSKN003和恩沃利单抗组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4552740_ZH52740_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["GLW","ADC","BK4588","BK4080","BK4585","LU0348723411.USD","BK4512","09966","IE00BFMHRM44.USD","BK4231","SITC","BK4148","BK1574","BK1161"],"gpt_icon":0},{"id":"2482824705","title":"康宁杰瑞逆势涨超8%，将在SITC年会公布研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2482824705","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482824705?lang=zh_cn&edition=full","pubTime":"2024-11-11 11:59","pubTimestamp":1731297596,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B(9966.HK)今日盘中逆势涨超8%，报4.47港元。消息面上，集团公布，自主研发用于治疗HER2表达晚期或转移性实体瘤的JSKN033I/II期临床试验，相关最新研究成果，获入选2024年癌症免疫治疗学会(SITC)年会最新突破性摘要，且于年会期间以壁报形式首次公布。JSKN033-101是一项开放、多中心及首次人体的I/II期临床试验，旨在评估JSKN033在晚期HER2表达实体瘤(IHC≥1+)或HER2突变非小细胞肺癌患者中的安全性、耐受性和初步有效性。\n\n\r\n 责任编辑：栎树","market":"sh","thumbnail":"http://imgcloud.jrjimg.cn/2024/11/cms_20241111115956612.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2024/11/cms_20241111115956612.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/11115945136939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BFMHRM44.USD","BK4585","BK4588","BK4080","BK4231","BK4148","SITC","LU0348723411.USD","GLW","BK4512"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sitecenters.com","stockEarnings":[{"period":"1week","weight":-0.037},{"period":"1month","weight":-0.1478},{"period":"3month","weight":-0.1839},{"period":"6month","weight":-0.789},{"period":"1year","weight":-0.7727},{"period":"ytd","weight":-0.1668}],"compareEarnings":[{"period":"1week","weight":-0.0228},{"period":"1month","weight":-0.0672},{"period":"3month","weight":-0.0685},{"period":"6month","weight":0.0014},{"period":"1year","weight":0.0929},{"period":"ytd","weight":-0.0397}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"SITE Centers Corp.拥有和管理露天购物中心,为零售合作伙伴和消费者提供有吸引力的购物体验和商品组合。该公司是一家自营和自我管理的房地产投资信托基金，是一家综合性房地产公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.46875,"avgChangeRate":0.000763},{"month":2,"riseRate":0.580645,"avgChangeRate":0.006952},{"month":3,"riseRate":0.636364,"avgChangeRate":-0.00295},{"month":4,"riseRate":0.5625,"avgChangeRate":0.032159},{"month":5,"riseRate":0.4375,"avgChangeRate":0.000981},{"month":6,"riseRate":0.75,"avgChangeRate":0.022019},{"month":7,"riseRate":0.65625,"avgChangeRate":0.015994},{"month":8,"riseRate":0.46875,"avgChangeRate":0.00249},{"month":9,"riseRate":0.46875,"avgChangeRate":-0.015322},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.04178},{"month":11,"riseRate":0.46875,"avgChangeRate":0.001368},{"month":12,"riseRate":0.625,"avgChangeRate":0.0148}],"exchange":"NYSE","name":"SITE Centers Corp.","nameEN":"SITE Centers Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.7","shortVersion":"4.31.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SITE Centers Corp.(SITC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SITE Centers Corp.(SITC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SITE Centers Corp.,SITC,SITE Centers Corp.股票,SITE Centers Corp.股票老虎,SITE Centers Corp.股票老虎国际,SITE Centers Corp.行情,SITE Centers Corp.股票行情,SITE Centers Corp.股价,SITE Centers Corp.股市,SITE Centers Corp.股票价格,SITE Centers Corp.股票交易,SITE Centers Corp.股票购买,SITE Centers Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SITE Centers Corp.(SITC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SITE Centers Corp.(SITC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}